Stephen T. Chambers
Impact in
- Clinical Biochemistry top 0.5%
- Endocrinology top 1%
Papers in
-
- Antifungal resistance and susceptibility 22
- Antimicrobial Resistance in Staphylococcus 15
- Epidemiology 56
- Urinary Tract Infections Management 13
- Co-authors
- Michael Lever (48 shared papers)David R. Murdoch (38 shared papers)Mona Syhre (8 shared papers)Sandy Slow (33 shared papers)Peter M. George (22 shared papers)C. M. Kunin (5 shared papers)Michael Epton (12 shared papers)Amy Scott-Thomas (24 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (10 papers)Journal of Infection (10 papers)PLoS ONE (9 papers)International Journal of Molecular Sciences (9 papers)Clinical Biochemistry (7 papers)
- Partner nations
- New ZealandUnited StatesAustralia
In The Last Decade
Stephen T. Chambers
258 papers receiving 7.7k citations
Peers
Comparison fields: 5 of 174
- Clinical Biochemistry 593
- Endocrinology 413
- Applied Microbiology and Biotechnology 127
- Infectious Diseases 1.2k
- Microbiology 49
Countries citing papers authored by Stephen T. Chambers
This map shows the geographic impact of Stephen T. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen T. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen T. Chambers more than expected).
Fields of papers citing papers by Stephen T. Chambers
This network shows the impact of papers produced by Stephen T. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen T. Chambers. The network helps show where Stephen T. Chambers may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen T. Chambers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 266 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 300 | |
| 2 | 1996 | 291 | |
| 3 | 2014 | 199 | |
| 4 | 2003 | 184 | |
| 5 | 2012 | 168 | |
| 6 | 2001 | 151 | |
| 7 | 1984 | 151 | |
| 8 | 2001 | 136 | |
| 9 | 2008 | 131 | |
| 10 | 2004 | 130 | |
| 11 | 2014 | 122 | |
| 12 | 2010 | 120 | |
| 13 | 2009 | 112 | |
| 14 | 1994 | 102 | |
| 15 | 1987 | 99 | |
| 16 | 2015 | 95 | |
| 17 | 1992 | 92 | |
| 18 | 2011 | 92 | |
| 19 | 2003 | 91 | |
| 20 | 1987 | 91 |
About Stephen T. Chambers
Stephen T. Chambers is a scholar working on Infectious Diseases, Epidemiology, Rheumatology, Pharmacology and Molecular Biology, having authored 266 papers that have together received 8.1k indexed citations. Recurring topics across this work include Folate and B Vitamins Research (31 papers), Antifungal resistance and susceptibility (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers), Advanced Chemical Sensor Technologies (16 papers), Legionella and Acanthamoeba research (15 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Metabolism and Genetic Disorders (15 papers) and Urinary Tract Infections Management (13 papers). The work is most often cited by research in Clinical Biochemistry (593 citations), Endocrinology (413 citations), Applied Microbiology and Biotechnology (127 citations), Infectious Diseases (1.2k citations) and Microbiology (49 citations). Stephen T. Chambers has collaborated with scholars based in New Zealand, United States and Australia. Frequent co-authors include Michael Lever, David R. Murdoch, Mona Syhre, Sandy Slow, Peter M. George, C. M. Kunin, Michael Epton, Amy Scott-Thomas, Alan Pithie and Evan J. Begg. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Infection, PLoS ONE, International Journal of Molecular Sciences and Clinical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.